The Valley Desk

NCT02305381 · Interventional trial

Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 Diabetes

Overall registry status Completed

Phase 3

Conditions Diabetes, Diabetes Mellitus, Type 2

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov